138.41 USD
-0.36 (-0.26%)
138.41 USD
0 (0%)
Taking everything into account, NHC scores 6 out of 10 in our fundamental rating. NHC was compared to 101 industry peers in the Health Care Providers & Services industry. While NHC has a great profitability rating, there are some minor concerns on its financial health. NHC has a valuation in line with the averages, but it does not seem to be growing. NHC also has an excellent dividend rating. This makes NHC very considerable for dividend investing!
1. Profitability
1.1 Basic Checks
NHC had positive earnings in the past year.
In the past year NHC had a positive cash flow from operations.
Each year in the past 5 years NHC has been profitable.
Each year in the past 5 years NHC had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.71%, NHC belongs to the top of the industry, outperforming 86.14% of the companies in the same industry.
NHC has a Return On Equity of 10.26%. This is in the better half of the industry: NHC outperforms 73.27% of its industry peers.
NHC's Return On Invested Capital of 6.69% is fine compared to the rest of the industry. NHC outperforms 65.35% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NHC is significantly below the industry average of 9.58%.
The last Return On Invested Capital (6.69%) for NHC is above the 3 year average (3.68%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROIC | 6.69% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
1.3 Margins
Looking at the Profit Margin, with a value of 7.19%, NHC belongs to the top of the industry, outperforming 86.14% of the companies in the same industry.
In the last couple of years the Profit Margin of NHC has grown nicely.
NHC has a Operating Margin of 7.99%. This is in the better half of the industry: NHC outperforms 74.26% of its industry peers.
In the last couple of years the Operating Margin of NHC has grown nicely.
With a decent Gross Margin value of 38.11%, NHC is doing good in the industry, outperforming 66.34% of the companies in the same industry.
NHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% |
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
2. Health
2.1 Basic Checks
NHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
NHC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NHC has more shares outstanding
Compared to 1 year ago, NHC has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.43 indicates that NHC is not in any danger for bankruptcy at the moment.
NHC has a Altman-Z score of 4.43. This is in the better half of the industry: NHC outperforms 79.21% of its industry peers.
The Debt to FCF ratio of NHC is 0.93, which is an excellent value as it means it would take NHC, only 0.93 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of NHC (0.93) is better than 90.10% of its industry peers.
NHC has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.10, NHC is doing good in the industry, outperforming 74.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Altman-Z | 4.43 |
ROIC/WACC0.75
WACC8.88%
2.3 Liquidity
NHC has a Current Ratio of 1.72. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
NHC's Current ratio of 1.72 is fine compared to the rest of the industry. NHC outperforms 67.33% of its industry peers.
A Quick Ratio of 1.69 indicates that NHC should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.69, NHC is doing good in the industry, outperforming 69.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 13.19% over the past year.
NHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.03% yearly.
Looking at the last year, NHC shows a very strong growth in Revenue. The Revenue has grown by 22.82%.
The Revenue has been growing slightly by 5.58% on average over the past years.
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.63, NHC is valued on the expensive side.
70.30% of the companies in the same industry are more expensive than NHC, based on the Price/Earnings ratio.
NHC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.77.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.63 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NHC indicates a somewhat cheap valuation: NHC is cheaper than 66.34% of the companies listed in the same industry.
NHC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. NHC is cheaper than 69.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.06 | ||
| EV/EBITDA | 11.58 |
4.3 Compensation for Growth
NHC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.57
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NHC has a Yearly Dividend Yield of 1.85%.
Compared to an average industry Dividend Yield of 0.60, NHC pays a better dividend. On top of this NHC pays more dividend than 91.09% of the companies listed in the same industry.
NHC's Dividend Yield is comparable with the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.85% |
5.2 History
The dividend of NHC has a limited annual growth rate of 3.30%.
NHC has been paying a dividend for at least 10 years, so it has a reliable track record.
NHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.3%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
NHC pays out 35.96% of its income as dividend. This is a sustainable payout ratio.
NHC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP35.96%
EPS Next 2YN/A
EPS Next 3YN/A
138.41
-0.36 (-0.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners62.45%
Inst Owner Change5.58%
Ins Owners7.08%
Ins Owner Change-0.08%
Market Cap2.15B
Revenue(TTM)1.46B
Net Income(TTM)104.80M
Analysts60
Price TargetN/A
Short Float %2.59%
Short Ratio4.36
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.85% |
Yearly Dividend2.4
Dividend Growth(5Y)3.3%
DP35.96%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.63 | ||
| Fwd PE | N/A | ||
| P/S | 1.47 | ||
| P/FCF | 18.06 | ||
| P/OCF | 14.41 | ||
| P/B | 2.1 | ||
| P/tB | 2.58 | ||
| EV/EBITDA | 11.58 |
EPS(TTM)6.71
EY4.85%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.66
FCFY5.54%
OCF(TTM)9.61
OCFY6.94%
SpS93.95
BVpS65.84
TBVpS53.58
PEG (NY)N/A
PEG (5Y)2.57
Graham Number99.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.71% | ||
| ROE | 10.26% | ||
| ROCE | 9.01% | ||
| ROIC | 6.69% | ||
| ROICexc | 8.35% | ||
| ROICexgc | 10.23% | ||
| OM | 7.99% | ||
| PM (TTM) | 7.19% | ||
| GM | 38.11% | ||
| FCFM | 8.16% |
ROA(3y)4.51%
ROA(5y)5.3%
ROE(3y)6.77%
ROE(5y)8.19%
ROIC(3y)3.68%
ROIC(5y)4.6%
ROICexc(3y)4.49%
ROICexc(5y)5.97%
ROICexgc(3y)5.54%
ROICexgc(5y)6.99%
ROCE(3y)4.96%
ROCE(5y)6.21%
ROICexgc growth 3Y-4%
ROICexgc growth 5Y11.11%
ROICexc growth 3Y-3.17%
ROICexc growth 5Y7.37%
OM growth 3Y-3.24%
OM growth 5Y5.6%
PM growth 3Y-15.45%
PM growth 5Y2.63%
GM growth 3Y-3.62%
GM growth 5Y-1.28%
F-Score4
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 0.93 | ||
| Debt/EBITDA | 0.64 | ||
| Cap/Depr | 68.45% | ||
| Cap/Sales | 2.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 92.81% | ||
| Profit Quality | 113.47% | ||
| Current Ratio | 1.72 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 4.43 |
F-Score4
WACC8.88%
ROIC/WACC0.75
Cap/Depr(3y)68.9%
Cap/Depr(5y)71.13%
Cap/Sales(3y)2.45%
Cap/Sales(5y)2.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.19%
EPS 3Y-10.09%
EPS 5Y8.03%
EPS Q2Q%-11.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.82%
Revenue growth 3Y6.76%
Revenue growth 5Y5.58%
Sales Q2Q%24.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.08%
EBIT growth 3Y3.3%
EBIT growth 5Y11.5%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y219.85%
FCF growth 3Y51.34%
FCF growth 5Y1.58%
OCF growth 1Y136.11%
OCF growth 3Y19.81%
OCF growth 5Y1.4%
NATIONAL HEALTHCARE CORP / NHC FAQ
What is the fundamental rating for NHC stock?
ChartMill assigns a fundamental rating of 6 / 10 to NHC.
What is the valuation status of NATIONAL HEALTHCARE CORP (NHC) stock?
ChartMill assigns a valuation rating of 4 / 10 to NATIONAL HEALTHCARE CORP (NHC). This can be considered as Fairly Valued.
How profitable is NATIONAL HEALTHCARE CORP (NHC) stock?
NATIONAL HEALTHCARE CORP (NHC) has a profitability rating of 8 / 10.
What are the PE and PB ratios of NATIONAL HEALTHCARE CORP (NHC) stock?
The Price/Earnings (PE) ratio for NATIONAL HEALTHCARE CORP (NHC) is 20.63 and the Price/Book (PB) ratio is 2.1.
How sustainable is the dividend of NATIONAL HEALTHCARE CORP (NHC) stock?
The dividend rating of NATIONAL HEALTHCARE CORP (NHC) is 7 / 10 and the dividend payout ratio is 35.96%.